Shineco Net Profit Margin 2016-2019 | TYHT

Shineco net profit margin from 2016 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
Shineco Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-12-31 $0.03B $-0.00B -6.45%
2019-09-30 $0.03B $-0.00B -3.23%
2019-06-30 $0.03B $0.00B 6.25%
2019-03-31 $0.03B $-0.00B -3.03%
2018-12-31 $0.04B $0.01B 13.16%
2018-09-30 $0.04B $0.01B 18.18%
2018-06-30 $0.04B $0.01B 18.18%
2018-03-31 $0.04B $0.01B 27.91%
2017-12-31 $0.04B $0.01B 23.68%
2017-09-30 $0.04B $0.01B 22.86%
2017-06-30 $0.03B $0.01B 24.24%
2017-03-31 $0.03B $0.01B 21.21%
2016-12-31 $0.03B $0.01B 21.21%
2016-09-30 $0.03B $0.01B 23.53%
2016-06-30 $0.04B $0.01B 22.86%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.012B $0.031B
Shineco, Inc. is principally engaged in the production and distribution of herbal medicines, organic agricultural produce, specialized textiles and other health and well-being focused plant-based products primarily in China. Shineco, Inc. is headquartered in Beijing, China.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $53.083B 30.71
Takeda Pharmaceutical (TAK) Japan $48.710B 8.54
Astellas Pharma (ALPMY) Japan $28.984B 14.48
Eisai (ESALY) Japan $20.745B 38.65
UCB SA (UCBJF) Belgium $16.296B 0.00
Grifols, S.A (GRFS) Spain $14.198B 17.65
Merck (MKGAF) Germany $13.006B 17.06
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.172B 227.03
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.163B 29.47
Ionis Pharmaceuticals (IONS) United States $6.879B 20.85
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.480B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.443B 6.64
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.553B 0.00
IPSEN SA ADR (IPSEY) France $4.515B 0.00
United Therapeutics (UTHR) United States $4.008B 0.00
Hypermarcas (HYPMY) Brazil $3.914B 11.90
Evotec AG (EVTCY) Germany $3.485B 56.21
Nektar Therapeutics (NKTR) United States $3.059B 0.00
FibroGen (FGEN) United States $2.945B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.859B 53.06
PTC Therapeutics (PTCT) United States $2.527B 0.00
ChemoCentryx (CCXI) United States $2.376B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.271B 9.19
Sage Therapeutics (SAGE) United States $1.635B 0.00
Xencor (XNCR) United States $1.621B 66.19
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.613B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.550B 18.85
Pacira Pharmaceuticals (PCRX) United States $1.334B 36.47
Theravance Biopharma (TBPH) Cayman Islands $1.331B 0.00
Karyopharm Therapeutics (KPTI) United States $1.283B 0.00
USANA Health Sciences (USNA) United States $1.279B 13.43
Corcept Therapeutics (CORT) United States $1.246B 13.94
CLINIGEN GP (CLIGF) United Kingdom $1.103B 0.00
Zogenix (ZGNX) United States $1.060B 0.00
Heron Therapeutics (HRTX) United States $1.021B 0.00
Esperion Therapeutics (ESPR) United States $0.971B 0.00
Tilray (TLRY) Canada $0.947B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.937B 29.03
Akebia Therapeutics (AKBA) United States $0.916B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.898B 12.50
Endo (ENDP) Ireland $0.787B 1.45
Translate Bio (TBIO) United States $0.649B 0.00
ImmunoGen (IMGN) United States $0.645B 0.00
Molecular Templates (MTEM) United States $0.645B 0.00
Radius Health (RDUS) United States $0.608B 0.00
Aerie Pharmaceuticals (AERI) United States $0.606B 0.00
Collegium Pharmaceutical (COLL) United States $0.561B 0.00
Portola Pharmaceuticals (PTLA) United States $0.536B 0.00
Indivior (INVVY) United States $0.480B 2.85
Catalyst Pharmaceuticals (CPRX) United States $0.390B 13.00
Innate Pharma SA (IPHYF) France $0.385B 0.00
Siga Technologies (SIGA) United States $0.384B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.378B 15.51
Corbus Pharmaceuticals Holdings (CRBP) United States $0.377B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.374B 0.00
Ardelyx (ARDX) United States $0.368B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.356B 0.00
Organogenesis Holdings (ORGO) United States $0.354B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.339B 0.00
Trillium Therapeutics (TRIL) Canada $0.328B 0.00
Flexion Therapeutics (FLXN) United States $0.317B 0.00
Calithera Biosciences (CALA) United States $0.311B 0.00
DURECT (DRRX) United States $0.305B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.295B 0.00
TherapeuticsMD (TXMD) United States $0.293B 0.00
Lannett Co Inc (LCI) United States $0.292B 4.71
Harpoon Therapeutics (HARP) United States $0.286B 0.00
Concert Pharmaceuticals (CNCE) United States $0.277B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.265B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.263B 0.00
Ocular Therapeutix (OCUL) United States $0.259B 0.00
CASI Pharmaceuticals (CASI) United States $0.206B 0.00
OptiNose (OPTN) United States $0.184B 0.00
Rafael Holdings (RFL) United States $0.183B 0.00
Jounce Therapeutics (JNCE) United States $0.161B 2.90
Recro Pharma (REPH) United States $0.155B 0.00
Nature's Sunshine Products (NATR) United States $0.152B 19.10
PROFOUND MEDICL (PROF) Canada $0.146B 0.00
MEI Pharma (MEIP) United States $0.142B 0.00
Taiwan Liposome (TLC) Taiwan $0.139B 0.00
KalVista Pharmaceuticals (KALV) United States $0.130B 0.00
VAXART, INC (VXRT) United States $0.123B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.119B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.102B 0.00
CannTrust Holdings (CTST) Canada $0.099B 0.00
Redhill Biopharma (RDHL) Israel $0.092B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.086B 0.00
IMV INC (IMV) Canada $0.084B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.081B 0.00
Champions Oncology (CSBR) United States $0.079B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.078B 0.00
Xeris Pharmaceuticals (XERS) United States $0.077B 0.00
Aquestive Therapeutics (AQST) United States $0.077B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.073B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.073B 0.00
SCYNEXIS (SCYX) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.069B 0.00
Biomerica (BMRA) United States $0.069B 0.00
Otonomy (OTIC) United States $0.063B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 16.43
Infinity Pharmaceuticals (INFI) United States $0.051B 0.00
Aclaris Therapeutics (ACRS) United States $0.047B 0.00
Nivalis Therapeutics (ALPN) United States $0.046B 0.00
PolarityTE (PTE) United States $0.045B 0.00
MediWound (MDWD) Israel $0.045B 0.00
Onconova Therapeutics (ONTX) United States $0.044B 0.00
PharmAthene (ALT) United States $0.044B 0.00
GTx (ONCT) United States $0.043B 0.00
Natural Alternatives (NAII) United States $0.043B 19.41
Neos Therapeutics (NEOS) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 131.14
Forward Pharma (FWP) Denmark $0.038B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.037B 0.00
Heat Biologics (HTBX) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.027B 0.00
Mannatechorporated (MTEX) United States $0.026B 8.05
Bellicum Pharmaceuticals (BLCM) United States $0.024B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.023B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.023B 0.00
Novan (NOVN) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
China SXT Pharmaceuticals (SXTC) China $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Vical (BBI) United States $0.013B 0.00
ElectroCore (ECOR) United States $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
KemPharm (KMPH) United States $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.008B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.001B 0.00